| Title: |
Brentuximab Vedotin (BV) in Combination With Lenalidomide (Len) and Rituximab (R) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Results From the Phase 3 ECHELON-3 Study |
| Authors: |
Yasenchak, Christopher; Kim, Jeong-A; Hahn, Uwe; Kim, Won-Seog; Fleury, Isabelle; Laribi, Kamel; Miguel Bergua Burgues, Juan; Bouabdallah, Krimo; Forward, Nicholas; Bijou, Fontanet; MacDonald, David; Portell, Craig; Ghesquieres, Herve; Nowakowski, Grzegorz; Rustia, Evelyn; Fanale, Michelle; Jie, Fei; Bartlett, Nancy |
| Source: |
Clinical Lymphoma Myeloma and Leukemia ; volume 24, page S220 ; ISSN 2152-2650 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2024 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/s2152-2650(24)00845-0 |
| Availability: |
http://dx.doi.org/10.1016/s2152-2650(24)00845-0; https://api.elsevier.com/content/article/PII:S2152265024008450?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S2152265024008450?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license |
| Accession Number: |
edsbas.5EC44784 |
| Database: |
BASE |